Correvio Pharma Corp. Operating Loss Carryforwards
Correvio Pharma Corp. had Operating Loss Carryforwards of $162.08 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2020-04-30
- 2019-12-31: Operating Loss Carryforwards $162.08M.
- 2018-12-31: Operating Loss Carryforwards $118.37M.
- 2017-12-31: Operating Loss Carryforwards $356.61M.
- 2016-12-31: Operating Loss Carryforwards $356.61M; Operating Loss Carryforwards as first filed $327.45M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2019-12-31 | $162.08M 20-F · filed 2020-04-30 | |
| 2018-12-31 | $118.37M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $356.61M 40-F · filed 2019-03-13 | |
| 2016-12-31 | $356.61M 20-F · filed 2018-04-30 | $327.45M 40-F · filed 2017-03-29 |
| 2015-12-31 | $313.06M 40-F · filed 2017-03-29 | |
| 2014-12-31 | $301.79M 40-F · filed 2016-03-29 | |
| 2013-12-31 | $292.75M 40-F · filed 2015-03-27 | |
| 2012-12-31 | $253.49M 40-F/A · filed 2014-04-30 | |
| 2011-12-31 | $223.54M 20-F/A · filed 2013-04-18 |